MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics, Inc. (FDMT)

||
||

Balance Sheets Overview

Current Ratio
803.30%
Quick Ratio
803.30%
Cash Ratio
147.61%
Debt to Asset Ratio
17.25%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Marketable securities, long-term
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Operating lease liabilities, lon...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
70,372
72,488
60,241
48,555
Marketable securities
290,962
318,404
342,414
256,508
Collaboration receivable
4,611
-
-
-
Prepaid expenses and other current assets
17,012
14,472
10,479
7,314
Total current assets
382,957
405,364
413,134
312,377
Marketable securities, long-term
69,295
66,739
111,379
67,165
Total property and equipment
35,823
36,136
36,146
36,216
Less accumulated depreciation and amortization
23,444
22,549
21,279
20,063
Property and equipment, net
12,379
13,587
14,867
16,153
Operating lease right-of-use assets, net
16,548
17,357
18,143
18,907
Other non-current assets
11,436
9,858
9,188
9,380
Total assets
492,615
512,905
566,711
423,982
Accounts payable
12,522
14,692
11,159
6,863
Accrued and other current liabilities
25,431
22,866
26,874
24,189
Deferred revenue
360
360
360
360
Deferred grant reimbursements
3,986
-
-
-
Operating lease liabilities, current portion
5,374
5,486
5,592
5,695
Total current liabilities
47,673
43,404
43,985
37,107
Deferred revenue, net of current portion
2,955
2,125
745
835
Derivative liability
384
370
358
345
Operating lease liabilities, long-term portion
14,256
15,049
15,821
16,568
Long-term debt, net
19,587
-
-
-
Other liabilities
101
121
138
144
Total liabilities
84,956
61,069
61,047
54,999
Common stock, 0.0001 par value, 300,000,000 shares authorized at june 30, 2026 and december 31, 2025 55,214,097 and 57,607,874 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
6
5
6
5
Additional paid-in-capital
1,266,099
1,237,075
1,221,235
1,104,008
Accumulated other comprehensive gain (loss)
-446
-180
727
671
Accumulated deficit
-858,000
-785,064
-716,304
-735,701
Total stockholders equity
407,659
451,836
505,664
368,983
Total liabilities and stockholders equity
492,615
512,905
566,711
423,982
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

FDMT Balance Sheet Sankey DiagramSankey diagram visualizing FDMT balance sheet for the periodMarketable securities$290,962K (34.66%↑ Y/Y)Cash and cashequivalents$70,372K (-8.80%↓ Y/Y)Prepaid expenses andother current assets$17,012K (69.07%↑ Y/Y)Collaboration receivable$4,611K Total property andequipment$35,823K (-1.33%↓ Y/Y)Total current assets$382,957K (26.27%↑ Y/Y)Marketable securities,long-term$69,295K (-44.03%↓ Y/Y)Operating leaseright-of-use assets, net$16,548K (-15.78%↓ Y/Y)Property and equipment,net$12,379K (-29.28%↓ Y/Y)Other non-currentassets$11,436K (21.79%↑ Y/Y)Less accumulateddepreciation and...$23,444K (24.69%↑ Y/Y)Total assets$492,615K (4.01%↑ Y/Y)Total liabilities andstockholders equity$492,615K (4.01%↑ Y/Y)Total stockholdersequity$407,659K (-3.14%↓ Y/Y)Total liabilities$84,956K (61.06%↑ Y/Y)Accumulated deficit-$858,000K (-26.39%↓ Y/Y)Accumulated othercomprehensive gain (loss)-$446K (-232.34%↓ Y/Y)Additionalpaid-in-capital$1,266,099K (15.17%↑ Y/Y)Total currentliabilities$47,673K (37.48%↑ Y/Y)Long-term debt, net$19,587K Operating leaseliabilities, long-term...$14,256K (-17.86%↓ Y/Y)Deferred revenue, net ofcurrent portion$2,955K (1249.32%↑ Y/Y)Derivative liability$384K (14.97%↑ Y/Y)Other liabilities$101K (-37.27%↓ Y/Y)Common stock, 0.0001par value,...$6K (20.00%↑ Y/Y)Accrued and othercurrent liabilities$25,431K (32.52%↑ Y/Y)Accounts payable$12,522K (43.93%↑ Y/Y)Operating leaseliabilities, current portion$5,374K (-6.07%↓ Y/Y)Deferred grantreimbursements$3,986K Deferred revenue$360K (-66.23%↓ Y/Y)